New 0604 Pthc Valya Irisa Laura Vanessafinal Version Guide

| | Rising variability in pre‑treatment assessment leads to delayed therapy initiation, sub‑optimal patient selection, and increased adverse‑event rates. | |------------|------------------------------------------------------------------------------------------------------------------------| | Problem | No unified, evidence‑based health‑check that aligns oncologists, radiologists, and nursing staff across sites. | | Purpose | Build a standardised, scalable, and predictive health‑check that: • Identifies high‑risk patients early • Reduces unnecessary investigations • Improves time‑to‑treatment by ≥ 15 % • Enhances patient satisfaction scores (> 4.5/5). |

| Metric | Baseline (pre‑PTHC) | Post‑Implementation (pilot) | % Change | |--------|---------------------|------------------------------|----------| | Median TTT (days) | 21 | 17 | | | High‑risk patients identified correctly (sensitivity) | — | 92 % | — | | Low‑risk false‑positive rate | — | 8 % | — | | Average number of unnecessary tests per patient | 2.3 | 1.1 | ‑52 % | | Patient satisfaction (5‑point scale) | 4.2 | 4.6 | +9 % | | Cost saving (per 1,000 patients) | — | $145,000 | — | New 0604 Pthc Valya Irisa Laura Vanessafinal Version

Instead of writing "Final," use version numbers ( v01 , v02 ). Only the file uploaded to the server or sent to the printer should be marked as FINAL . Better: PTHC_Valya_Irisa_v04 3. Metadata is Your Friend | | Rising variability in pre‑treatment assessment leads